Called ThioZymeYD, the dietary supplement aims to promote digestive health by maintaining an optimal level of healthy yeast in the gut.
A new digestive-health dietary supplement has launched from ingredient supplier and contract manufacturer Deerland Enzymes (Kennesaw, GA). Called ThioZymeYD, the dietary supplement aims to promote digestive health by maintaining an optimal level of healthy yeast in the gut.
ThioZyme YD is a blend of peptides, essential oils, chelators, and enzymes that support normal yeast population in the gut, such as the Candida species. By contrast, the firm says, an abnormal population, or overgrowth, of yeast in the gut can lead to abdominal pain and bloating, intestinal gas and diarrhea, or constipation.
“When Candida overgrowth occurs in the small intestine, it is difficult to correct,” explains Deerland Enzyme’s vice president of technology, John Deaton, PhD. “The yeast binds to the lining of the small intestine and mounts its own defense mechanism, preventing the body from removing it, causing harm to the digestive tract.” Deaton says that ThioZymeYD disrupts that defense mechanism and returns yeast levels to standard levels, allowing the body’s natural defenses to reestablish a normal microflora population.
ThioZyme’s launch is third launch to result from a partnership between Deerland Enzymes and Thione International (Atlanta). The two companies have been collaborating on product formulations that combine both companies’ ingredient specialties. Last September, the firms debuted an antioxidant-enzyme blend, ThioZyme, which the companies say has twice the antioxidant capacity compared with glutathione.
Thione’s president and CEO Theodore Hersh, MD, is the former co-director of the Division of Digestive Diseases at Emory University School of Medicine.
Deerland Enzymes specializes in plant, animal, fungal, and bacterial-sourced enzymes.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.
New review paper highlights gut-brain benefits of novel herbal blend, Digexin
September 16th 2024NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.